The Ozempic Effect

What do once-weekly injections, oral GLP-1 tablets, and smart drug-delivery patches have in common? They all began as patented ideas. Ozempic’s USD 49 billion market is fueling a patent sprint in semaglutide. Find the leaders and how advances from peptide design to metabolic therapies will open the door to biosimilars after 2030. Get the full picture with PatSeer’s patent search, analytics, and monitoring tools.